Metformin as an adjuvant option for systemic treatment of breast cancer

Metformin as an adjuvant option for systemic treatment of breast cancer

The modification of the used and development of new treatment regimens significantly improved the overall, recurrence-free survival and quality of life of patients with malignant oncological diseases. Recently, drugs used in non-oncological pathology have been introduced into cancer treatment regime...

Full description

Bibliographic Details
Main Authors:	D.I. Avierin, V.F. Zavizion
Format:	Article
Language:	English
Published:	Dnipro State Medical University 2023-12-01
Series:	Medičnì Perspektivi
Subjects:	breast cancer metformin chemotherapy modification neoadjuvant treatment luminal type medical resistance survive of patient
Online Access:	https://journals.uran.ua/index.php/2307-0404/article/view/294154

Similar Items

Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment
by: Nourhan M. Essa, et al.
Published: (2022-09-01)

RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients
by: Haibo Wang, et al.
Published: (2022-12-01)

Metformin in neoadjuvant systemic therapy of breast cancer patients with metabolic syndrome
by: Liubota Roman, et al.
Published: (2018-01-01)

Association of <i>SLC12A1</i> and GLUR4 Ion Transporters with Neoadjuvant Chemoresistance in Luminal Locally Advanced Breast Cancer
by: Montserrat Justo-Garrido, et al.
Published: (2023-11-01)

Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?
by: Eric Zandirad, et al.
Published: (2022-11-01)

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting
by: Antonino Grassadonia, et al.
Published: (2021-07-01)

Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival
by: Gilles Houvenaeghel, et al.
Published: (2024-02-01)

Metformin as a Potential Treatment Option for Endometriosis
by: Żaneta Kimber-Trojnar, et al.
Published: (2022-01-01)

Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer
by: Jan Haussmann, et al.
Published: (2022-08-01)

New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
by: Junsha An, et al.
Published: (2021-09-01)

Role of metformin in radiotherapy and chemotherapy
by: Yasemin Benderli Cihan
Published: (2019-03-01)

Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
by: Jiangfeng Wu, et al.
Published: (2022-11-01)

DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival
by: Christine Aaserød Pedersen, et al.
Published: (2022-06-01)

The experience of preoperative treatment with anthracyclines in patients with luminal-type B locally advanced breast cancer
by: D. Ye. Cherniavskyi, et al.
Published: (2022-09-01)

Colour Coding Navigation: “Triage” Techniques to Improve Compliance in Breast Cancer Patients Requiring Primary Chemotherapy
by: Carol Ann Benn, et al.
Published: (2020-10-01)

Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
by: Serhat Sekmek, et al.
Published: (2023-11-01)

Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study
by: Pengfei Su, et al.
Published: (2023-10-01)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
by: V F Semiglazov, et al.
Published: (2013-12-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)

Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study
by: Jida Chen, et al.
Published: (2023-01-01)

Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
by: Mhdia Osman, et al.
Published: (2023-01-01)

Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study
by: Yuting Sang, et al.
Published: (2022-10-01)

Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress
by: Yushi Chen, et al.
Published: (2023-10-01)

Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect
by: Lin Zhu, et al.
Published: (2024-06-01)

Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
by: Hai-Fei Niu, et al.
Published: (2016-03-01)

The Magee 3 Equation Predicts Favorable Pathologic Response to Neoadjuvant Endocrine Therapy in Breast Cancer Patients
by: Carlos Eduardo Paiva, et al.
Published: (2024-01-01)

Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
by: L. Lukas Löfling, et al.
Published: (2023-08-01)

Study of feasibility and efficacy of neoadjuvant chemotherapy in cases of locally advanced breast cancer
by: Arun V Dawle, et al.
Published: (2015-01-01)

Abbreviated breast MRI for evaluating breast cancer before initiation of neoadjuvant chemotherapy: A cross-sectional study
by: Arvin Arian, et al.
Published: (2023-12-01)

Outcomes of Triple-Negative Breast Cancer Patients in Response to Taxane and Nontaxane-Based Neoadjuvant Chemotherapies
by: Mohsin Khan, et al.
Published: (2022-06-01)

Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis
by: Yifan Lu, et al.
Published: (2023-05-01)

Survival Outcomes of Patients with Locally Advanced Breast Cancer after Neoadjuvant Systemic Therapy in St. Luke’s Medical Center
by: Cristina G. Domingo, et al.
Published: (2023-05-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: K Alimoghadam, et al.
Published: (2004-03-01)

Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment
by: Haneen A. Basheer, et al.
Published: (2023-10-01)

Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
by: Giovanni Tossetta
Published: (2022-10-01)

Magnetic resonance imaging of the breast– where are we in 2021?
by: Mirta Zekan-Vučetić, et al.
Published: (2021-01-01)

The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer
by: Aurelio Bartolome Castrellon, et al.
Published: (2017-03-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Platinum-based adjuvant therapy was efficient for triple-negative breast cancer: a meta-analysis from randomized controlled trials
by: Kaigang Xie, et al.
Published: (2022-06-01)

A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival
by: Carlos A. Barrón-Gallardo, et al.
Published: (2022-10-01)